These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36265990)

  • 1. What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
    Rosenthal M; Schawkat K; Muftah M; Jajoo K
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):911-928. PubMed ID: 36265990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
    Wartski M; Sauvanet A
    Diagn Interv Imaging; 2019 Dec; 100(12):735-741. PubMed ID: 31402332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
    Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
    Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
    AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography.
    Yamada K; Kawashima H; Ohno E; Ishikawa T; Tanaka H; Nakamura M; Miyahara R; Ishigami M; Hirooka Y; Fujishiro M
    BMC Gastroenterol; 2020 Mar; 20(1):81. PubMed ID: 32228472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma.
    Balci NC; Semelka RC
    Eur J Radiol; 2001 May; 38(2):105-12. PubMed ID: 11335092
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Palmieri LJ; Coriat R
    Diagn Interv Imaging; 2019 Dec; 100(12):731-733. PubMed ID: 31780041
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma.
    Rhee H; Park MS
    Korean J Radiol; 2021 Jan; 22(1):23-40. PubMed ID: 32901458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
    Ciaravino V; Cardobi N; DE Robertis R; Capelli P; Melisi D; Simionato F; Marchegiani G; Salvia R; D'Onofrio M
    Anticancer Res; 2018 Aug; 38(8):4889-4895. PubMed ID: 30061265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET and PET-CT of malignant tumors of the exocrine pancreas].
    Reske SN
    Radiologe; 2009 Feb; 49(2):131-6. PubMed ID: 19219476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
    Bowman AW; Bolan CW
    Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
    Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
    Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
    Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
    Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?
    Clanton J; Oh S; Kaplan SJ; Johnson E; Ross A; Kozarek R; Alseidi A; Biehl T; Picozzi VJ; Helton WS; Coy D; Dorer R; Rocha FG
    HPB (Oxford); 2018 Oct; 20(10):925-931. PubMed ID: 29753633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Ductal Adenocarcinoma: The Dawn of the Era of Nuclear Medicine?
    Montemagno C; Cassim S; De Leiris N; Durivault J; Faraggi M; Pagès G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of endoscopic ultrasound in pancreatic cancer.
    Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
    World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.